Citations (108)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Jeffrey Q. Nguyen & Rosalyn B. Irby. (2017) TRIM21 is a novel regulator of Par-4 in colon and pancreatic cancer cells. Cancer Biology & Therapy 18:1, pages 16-25.
Read now
Read now
Wu Qinan, Zhang Ling & Chen Bing. (2014) PAR-4: a possible new target for age-related disease. Expert Opinion on Therapeutic Targets 18:8, pages 917-927.
Read now
Read now
Rosalyn B Irby & Christina LB Kline. (2013) Par-4 as a potential target for cancer therapy. Expert Opinion on Therapeutic Targets 17:1, pages 77-87.
Read now
Read now
Asfar S Azmi, Philip A Philip, Syed F Zafar, Fazlul H Sarkar & Ramzi M Mohammad. (2010) PAR-4 as a possible new target for pancreatic cancer therapy. Expert Opinion on Therapeutic Targets 14:6, pages 611-620.
Read now
Read now
Howard Donninger, Luke Hesson, Michele Vos, Kristin Beebe, Laura Gordon, David Sidransky, Jun Wei Liu, Thomas Schlegel, Shannon Payne, Arndt Hartmann, Farida Latif & Geoffrey J. Clark. (2010) The Ras Effector RASSF2 Controls the PAR-4 Tumor Suppressor. Molecular and Cellular Biology 30:11, pages 2608-2620.
Read now
Read now
Sarah Appel, Susanne Vetterkind, Ansgar Koplin, Barbara Maertens, Meike Boosen & Ute Preuss. (2009) EFP1 is an ER stress-induced glycoprotein which interacts with the pro-apoptotic protein Par-4. Cell Health and Cytoskeleton 1, pages 1-16.
Read now
Read now
Articles from other publishers (102)
Min Tang, Leilei Zhai, Juanjuan Chen, Feng Wang, Haimin Chen & Wei Wu. (2023) The Antitumor Potential of λ-Carrageenan Oligosaccharides on Gastric Carcinoma by Immunomodulation. Nutrients 15:9, pages 2044.
Crossref
Crossref
Samjhana Pandey, Krishna K. Raut, Andrea M. Clark, Antoine Baudin, Lamya Djemri, David S. Libich, Komala Ponniah & Steven M. Pascal. (2023) Enhancing the Conformational Stability of the cl-Par-4 Tumor Suppressor via Site-Directed Mutagenesis. Biomolecules 13:4, pages 667.
Crossref
Crossref
Vinay Sonawane, Jeevan Ghosalkar, Swati Achrekar & Kalpana Joshi. (2023) Ketorolac modulates Rac-1/HIF-1α/DDX3/β-catenin signalling via a tumor suppressor prostate apoptosis response-4 (Par-4) in renal cell carcinoma. Scientific Reports 13:1.
Crossref
Crossref
Vanessa Mylenna Florêncio de Carvalho, Priscilla Stela Santana de Oliveira, Simão Kalebe Silva de Paula, Amanda Pinheiro de Barros Albuquerque, Moacyr Jesus Barreto de Melo Rêgo, Maira Galdino da Rocha Pitta & Michelly Cristiny Pereira. (2022) Vitamin D Modulates PAR-4 Expression in an in Vitro Model of Osteoarthritis. Brazilian Archives of Biology and Technology 65.
Crossref
Crossref
Daniel Bastida-Ruiz, Alexia Childress & Marie Cohen. 2022. Tumor Suppressor Par-4. Tumor Suppressor Par-4
209
238
.
Margaux Sevin, John E. Eriksson, Valérie Mezger, Carmen Garrido & Aurélie de Thonel. 2022. Tumor Suppressor Par-4. Tumor Suppressor Par-4
185
208
.
Nikhil Hebbar & Vivek M. Rangnekar. 2022. Tumor Suppressor Par-4. Tumor Suppressor Par-4
151
183
.
J. Labahn & U. K. Tiruttani Subhramanyam. 2022. Tumor Suppressor Par-4. Tumor Suppressor Par-4
127
150
.
Sehamuddin Galadari, Anees Rahman Cheratta & Faisal Thayyullathil. 2022. Tumor Suppressor Par-4. Tumor Suppressor Par-4
263
291
.
Saptadwipa Ganguly, Ravshan Burikhanov, Shirley Qiu & Vivek M. Rangnekar. 2022. Tumor Suppressor Par-4. Tumor Suppressor Par-4
1
59
.
Krishna Raut, Komala Ponniah & Steven Pascal. (2021) Structural Analysis of the cl-Par-4 Tumor Suppressor as a Function of Ionic Environment. Biomolecules 11:3, pages 386.
Crossref
Crossref
Anees Rahman Cheratta, Faisal Thayyullathil, Siraj Pallichankandy, Karthikeyan Subburayan, Ameer Alakkal & Sehamuddin Galadari. (2021) Prostate apoptosis response-4 and tumor suppression: it’s not just about apoptosis anymore. Cell Death & Disease 12:1.
Crossref
Crossref
Archana Katoch, Vijay Lakshmi Jamwal, Mir Mohd Faheem, Sriram Kumar, Shantibhusan Senapati, Govind Yadav, Sumit G. Gandhi & Anindya Goswami. (2021) Overlapping targets exist between the Par-4 and miR-200c axis which regulate EMT and proliferation of pancreatic cancer cells. Translational Oncology 14:1, pages 100879.
Crossref
Crossref
Joseph T. Greene, Mary K. McKenna, Subbarao Bondada & Natarajan Muthusamy. 2021. Tumor Suppressor Par-4. Tumor Suppressor Par-4
149
159
.
Sunil K. Noothi, Mary K. McKenna, Sara S. Alhakeem, James P. Collard, J. T. Greene, Natarajan Muthusamy, Vivek M. Rangnekar & Subbarao Bondada. 2021. Tumor Suppressor Par-4. Tumor Suppressor Par-4
133
148
.
Simone Aparecida de Bessa-Garcia & Maria Aparecida Nagai. 2021. Tumor Suppressor Par-4. Tumor Suppressor Par-4
113
131
.
François Fabi, Pascal Adam & Eric Asselin. 2021. Tumor Suppressor Par-4. Tumor Suppressor Par-4
41
58
.
Ravshan Burikhanov & Vivek M. Rangnekar. 2021. Tumor Suppressor Par-4. Tumor Suppressor Par-4
313
320
.
Peng Wang & Zhonglin Hao. 2021. Tumor Suppressor Par-4. Tumor Suppressor Par-4
303
311
.
Nathalia Araujo, Nikhil Hebbar & Vivek M. Rangnekar. 2021. Tumor Suppressor Par-4. Tumor Suppressor Par-4
289
301
.
Lu Ren & Shaolin Shi. 2021. Tumor Suppressor Par-4. Tumor Suppressor Par-4
281
288
.
Tahseen Ahmed, Tuneer Ranjan Mallick, Michael A. Walter & Moulinath Acharya. 2021. Tumor Suppressor Par-4. Tumor Suppressor Par-4
255
267
.
Qi Nan Wu, Ling Zhang & Bing Chen. 2021. Tumor Suppressor Par-4. Tumor Suppressor Par-4
247
253
.
Md. Hafiz Uddin, Asfar S. Azmi & Ramzi M. Mohammad. 2021. Tumor Suppressor Par-4. Tumor Suppressor Par-4
161
170
.
Mir Mohd Faheem, Archana Katoch & Anindya Goswami. 2021. Tumor Suppressor Par-4. Tumor Suppressor Par-4
1
23
.
Suji George, Rajlakshmi Viswanathan & Gajanan N. Sapkal. (2019) Molecular aspects of the teratogenesis of rubella virus. Biological Research 52:1.
Crossref
Crossref
Andrea M. Clark, Komala Ponniah, Meghan S. Warden, Emily M. Raitt, Benjamin G. Smith & Steven M. Pascal. (2019) Tetramer formation by the caspase‐activated fragment of the Par‐4 tumor suppressor. The FEBS Journal 286:20, pages 4060-4073.
Crossref
Crossref
J. T. Greene, Rajeswaran Mani, Rahul Ramaswamy, Frank Frissora, Max Yano, Kevan Zapolnik, Bonnie Harrington, Ronni Wasmuth, Minh Tran, Xiaokui Mo, Mary McKenna, Vivek M. Rangnekar, John C. Byrd, Subbarao Bondada & Natarajan Muthusamy. (2019) Par-4 overexpression impedes leukemogenesis in the Eµ-TCL1 leukemia model through downregulation of NF-κB signaling. Blood Advances 3:8, pages 1255-1266.
Crossref
Crossref
Renata Virgínia Cavalcanti Santos, Wanessa Layssa Batista de Sena, Flaviana Alves dos Santos, Antônio Felix da Silva Filho, Marina Galdino da Rocha Pitta, Maira Galdino da Rocha Pitta, Moacyr Barreto de Melo Rego & Michelly Cristiny Pereira. (2019) Potential Therapeutic Agents Against Par-4 Target for Cancer Treatment: Where Are We Going?. Current Drug Targets 20:6, pages 635-654.
Crossref
Crossref
Sonica Chaudhry, Vibhor Joshi, Naveen Bojjireddy, Maikho Thoh, Santosh K. Sandur & Gosukonda Subrahmanyam. (2019) Silencing of type II phosphatidylinositol 4-kinase β stabilizes prostate apoptosis response-4 and induces apoptosis in cancer cells. Biochemical Journal 476:2, pages 405-419.
Crossref
Crossref
Andrea Clark, Komala Ponniah, Meghan Warden, Emily Raitt, Andrea Yawn & Steven Pascal. (2018) pH-Induced Folding of the Caspase-Cleaved Par-4 Tumor Suppressor: Evidence of Structure Outside of the Coiled Coil Domain. Biomolecules 8:4, pages 162.
Crossref
Crossref
François Fabi, Pascal Adam, Keven Vincent, Françis Demontigny, Sophie Parent, France-Hélène Joncas & Eric Asselin. (2018) Inhibition of CRM1 activity sensitizes endometrial and ovarian cell lines to TRAIL-induced cell death. Cell Communication and Signaling 16:1.
Crossref
Crossref
Peng Wang, Ravshan Burikhanov, Rani Jayswal, Heidi L. Weiss, Susanne M. Arnold, John L. Villano & Vivek M. Rangnekar. (2018) Neoadjuvant administration of hydroxychloroquine in a phase 1 clinical trial induced plasma Par-4 levels and apoptosis in diverse tumors. Genes & Cancer 9:5-6, pages 190-197.
Crossref
Crossref
Nathaniel W. Mabe, Douglas B. Fox, Ryan Lupo, Amy E. Decker, Stephanie N. Phelps, J. Will Thompson & James V. Alvarez. (2018) Epigenetic silencing of tumor suppressor Par-4 promotes chemoresistance in recurrent breast cancer. Journal of Clinical
Investigation 128:10, pages 4413-4428.
Crossref
Crossref
Mary K. McKenna, Sunil K. Noothi, Sara S. Alhakeem, Karine Z. Oben, Joseph T. Greene, Rajeswaran Mani, Kathryn L. PerryJames P. Collard, Jacqueline R. Rivas, Gerhard C. Hildebrandt, Roger A. Fleischman, Eric B. Durbin, John C. Byrd, Chi Wang, Natarajan Muthusamy, Vivek M. RangnekarSubbarao Bondada. (2018) Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemia. Blood 131:26, pages 2943-2954.
Crossref
Crossref
Yi-Chun Yeh, Chin-Chyuan Chang, Pai-Po Lee & Winton Cheng. (2017) The transcription of atypical protein kinase C in hemocytes of the giant freshwater prawn, Macrobrachium rosenbergii , during the molt stage and injection of pathogen-associated compounds. Fish & Shellfish Immunology 69, pages 52-58.
Crossref
Crossref
Udaya K Tiruttani Subhramanyam, Jan Kubicek, Ulf B Eidhoff & Joerg Labahn. (2017) Structural basis for the regulatory interactions of proapoptotic Par-4. Cell Death & Differentiation 24:9, pages 1540-1547.
Crossref
Crossref
Simone Aparecida De Bessa Garcia, Ana Carolina Pavanelli, Natália Cruz E Melo & Maria Aparecida Nagai. (2017) Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity. International Journal of Molecular Medicine 39:4, pages 809-818.
Crossref
Crossref
James Sledziona & Vivek M. Rangnekar. 2017. TRAIL, Fas Ligand, TNF and TLR3 in Cancer. TRAIL, Fas Ligand, TNF and TLR3 in Cancer
91
106
.
Reyaz Ur Rasool, Debasis Nayak, Souneek Chakraborty, Archana Katoch, Mir Mohd Faheem, Hina Amin & Anindya Goswami. (2016) A journey beyond apoptosis: new enigma of controlling metastasis by pro-apoptotic Par-4. Clinical & Experimental Metastasis 33:8, pages 757-764.
Crossref
Crossref
Kevin Brasseur, François Fabi, Pascal Adam, Sophie Parent, Laurent Lessard & Eric Asselin. (2016) Post-translational regulation of the cleaved fragment of Par-4 in ovarian and endometrial cancer cells. Oncotarget 7:24, pages 36971-36987.
Crossref
Crossref
Seon Min Woo & Taeg Kyu Kwon. (2016) Par-4 Modulates Cell Migration through Inhibition of MMP-2 Activity in Human Renal Carcinoma Caki Cells. Journal of Life Science 26:5, pages 614-619.
Crossref
Crossref
KAI YANG, JIE SHEN, SHAN-WEN CHEN, JIE QIN, XIANG-YI ZHENG & LI-PING XIE. (2016) Upregulation of PAWR by small activating RNAs induces cell apoptosis in human prostate cancer cells. Oncology Reports 35:4, pages 2487-2493.
Crossref
Crossref
T P Das, S Suman, H Alatassi, M K Ankem & C Damodaran. (2016) Inhibition of AKT promotes FOXO3a-dependent apoptosis in prostate cancer. Cell Death & Disease 7:2, pages e2111-e2111.
Crossref
Crossref
Wu QiNan, Gan XiaGuang, Lei XiaoTian, Deng WuQuan, Zhang Ling & Chen Bing. (2016)
Par-4/NF-
κ
B Mediates the Apoptosis of Islet
β
Cells Induced by Glucolipotoxicity
. Journal of Diabetes Research 2016, pages 1-17.
Crossref
Crossref
Seon Min Woo & Taeg Kyu Kwon. (2015) Prostate Apoptosis Response-4 (Par-4) as a Cancer Therapeutic Target. Journal of Life Science 25:8, pages 947-952.
Crossref
Crossref
Avinash Appukuttan, Jan-Paul Flacke, Hanna Flacke, Alexandra Posadowsky, H. Peter Reusch & Yury Ladilov. (2014) Inhibition of soluble adenylyl cyclase increases the radiosensitivity of prostate cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1842:12, pages 2656-2663.
Crossref
Crossref
X Chen, A A Sahasrabuddhe, P Szankasi, F Chung, V Basrur, V M Rangnekar, M Pagano, M S Lim & K S J Elenitoba-Johnson. (2014) Fbxo45-mediated degradation of the tumor-suppressor Par-4 regulates cancer cell survival. Cell Death & Differentiation 21:10, pages 1535-1545.
Crossref
Crossref
William T. Senapedis, Erkan Baloglu & Yosef Landesman. (2014) Clinical translation of nuclear export inhibitors in cancer. Seminars in Cancer Biology 27, pages 74-86.
Crossref
Crossref
Ling-Jung Wang, Peir-Rong Chen, Lee-Ping Hsu, Wen-Lin Hsu, Dai-Wei Liu, Chung-Hsing Chang, Yih-Chih Hsu & Jeng-Woei Lee. (2014) Concomitant Induction of Apoptosis and Autophagy by Prostate Apoptosis Response-4 in Hypopharyngeal Carcinoma Cells. The American Journal of Pathology 184:2, pages 418-430.
Crossref
Crossref
A de Thonel, A Hazoumé, V Kochin, K Isoniemi, G Jego, E Fourmaux, A Hammann, H Mjahed, O Filhol, O Micheau, P Rocchi, V Mezger, J E Eriksson, V M Rangnekar & C Garrido. (2014) Regulation of the proapoptotic functions of prostate apoptosis response-4 (Par-4) by casein kinase 2 in prostate cancer cells. Cell Death & Disease 5:1, pages e1016-e1016.
Crossref
Crossref
Nikhil Hebbar, Tripti Shrestha-Bhattarai & Vivek M. Rangnekar. 2014. Anticancer Genes. Anticancer Genes
155
166
.
MICHELLY C. PEREIRA, SIMONE A. DE BESSA-GARCIA, RAVSHAN BURIKHANOV, ANA CAROLINA PAVANELLI, LOURIVAL ANTUNES, VIVEK M. RANGNEKAR & MARIA A. NAGAI. (2013) Prostate apoptosis response-4 is involved in the apoptosis response to docetaxel in MCF-7 breast cancer cells. International Journal of Oncology 43:2, pages 531-538.
Crossref
Crossref
James V. Alvarez, Tien-chi Pan, Jason Ruth, Yi Feng, Alice Zhou, Dhruv Pant, Joshua S. Grimley, Thomas J. Wandless, Angela DeMichele & Lewis A. Chodosh. (2013) Par-4 Downregulation Promotes Breast Cancer Recurrence by Preventing Multinucleation following Targeted Therapy. Cancer Cell 24:1, pages 30-44.
Crossref
Crossref
Kai Yang, Jie Shen, Yan-Qi Xie, Yi-Wei Lin, Jie Qin, Qi-Qi Mao, Xiang-Yi Zheng & Li-Ping Xie. (2013) Promoter-targeted double-stranded small RNAs activate PAWR gene expression in human cancer cells. The International Journal of Biochemistry & Cell Biology 45:7, pages 1338-1346.
Crossref
Crossref
Justin A. MacDonald, Lori D. Moffat, Abdulhameed Al-Ghabkari, Cindy Sutherland & Michael P. Walsh. (2013) Prostate-apoptosis response-4 phosphorylation in vascular smooth muscle. Archives of Biochemistry and Biophysics 535:1, pages 84-90.
Crossref
Crossref
Shuai Yu, He Huang, Anton Iliuk, Wen-Horng Wang, Keerthi B. Jayasundera, W.Andy Tao, Carol B. Post & Robert L. Geahlen. (2013) Syk Inhibits the Activity of Protein Kinase A by Phosphorylating Tyrosine 330 of the Catalytic Subunit. Journal of Biological Chemistry 288:15, pages 10870-10881.
Crossref
Crossref
Faisal Thayyullathil, Siraj Pallichankandy, Anees Rahman, Jaleel Kizhakkayil, Shahanas Chathoth, Mahendra Patel & Sehamuddin Galadari. (2013) Caspase-3 mediated release of SAC domain containing fragment from Par-4 is necessary for the sphingosine-induced apoptosis in Jurkat cells. Journal of Molecular Signaling 8, pages 2.
Crossref
Crossref
Asfar S. Azmi, Amro Aboukameel, Bin Bao, Fazlul H. Sarkar, Philip A. Philip, Michael Kauffman, Sharon Shacham & Ramzi M. Mohammad. (2013) Selective Inhibitors of Nuclear Export Block Pancreatic Cancer Cell Proliferation and Reduce Tumor Growth in Mice. Gastroenterology 144:2, pages 447-456.
Crossref
Crossref
Ravshan Burikhanov, Tripti Shrestha-Bhattarai, Shirley Qiu, Nidhi Shukla, Nikhil Hebbar, Subodh M. Lele, Craig Horbinski & Vivek M. Rangnekar. (2013) Novel Mechanism of Apoptosis Resistance in Cancer Mediated by Extracellular PAR-4. Cancer Research 73:2, pages 1011-1019.
Crossref
Crossref
Pranav Danthi, Geoffrey H. Holm, Thilo Stehle & Terence S. Dermody. 2013. Viral Entry into Host Cells. Viral Entry into Host Cells
42
71
.
Nidhi Shukla, Nikhil K. Hebbar & Vivek M. Rangnekar. 2013. Prostate Cancer. Prostate Cancer
481
495
.
Nikhil Hebbar, Chi Wang & Vivek M. Rangnekar. (2012) Mechanisms of apoptosis by the tumor suppressor Par-4. Journal of Cellular Physiology 227:12, pages 3715-3721.
Crossref
Crossref
Dongxiao Zhuang, Yingchao Liu, Ying Mao, Liang Gao, Haishi Zhang, Shihai Luan, Fengping Huang & Qingquan Li. (2012) TMZ-induced PrPc/par-4 interaction promotes the survival of human glioma cells. International Journal of Cancer 130:2, pages 309-318.
Crossref
Crossref
Deepak K. Sharma, Bilal Rah, Mallikharjuna R. Lambu, Altaf Hussain, Syed K. Yousuf, Anil K. Tripathi, Baldev Singh, Gayatri Jamwal, Zabeer Ahmed, Nayan Chanauria, Amit Nargotra, Anindya Goswami & Debaraj Mukherjee. (2012) Design and synthesis of novel N,N′-glycoside derivatives of 3,3′-diindolylmethanes as potential antiproliferative agents. MedChemComm 3:9, pages 1082.
Crossref
Crossref
Yan Zhang, Xihong Xing, Hongfeng Zhan, Qiaoyu Li, Yu Fan, Liping Zhan, Qiang Yu & Jian Chen. (2011) EGFR inhibitor enhances cisplatin sensitivity of human glioma cells. Journal of Huazhong University of Science and Technology [Medical Sciences] 31:6, pages 773-778.
Crossref
Crossref
Christina Leah B. Kline & Rosalyn B. Irby. (2011) The pro-apoptotic protein Prostate Apoptosis Response Protein-4 (Par-4) can be activated in colon cancer cells by treatment with Src inhibitor and 5-FU. Apoptosis 16:12, pages 1285-1294.
Crossref
Crossref
Ferry Sandra & Roya Khosravi-Far. (2011) Phosphorylated-Survivin at Ser81 Induced Protein Kinase A (PKA): A Back Loop. The Indonesian Biomedical Journal 3:2, pages 138.
Crossref
Crossref
Arun K. Sharma, Christina L. Kline, Arthur Berg, Shantu Amin & Rosalyn B. Irby. (2011) The Akt Inhibitor ISC-4 Activates Prostate Apoptosis Response Protein-4 and Reduces Colon Tumor Growth in a Nude Mouse Model. Clinical Cancer Research 17:13, pages 4474-4483.
Crossref
Crossref
Carolina S. Ilkow, Ing Swie Goping & Tom C. Hobman. (2011) The Rubella Virus Capsid Is an Anti-Apoptotic Protein that Attenuates the Pore-Forming Ability of Bax. PLoS Pathogens 7:2, pages e1001291.
Crossref
Crossref
Bi-Dar Wang, Christina Leah B. Kline, Danielle M. Pastor, Thomas L. Olson, Bryan Frank, Truong Luu, Arun K. Sharma, Gavin Robertson, Matthew T. Weirauch, Steven R. Patierno, Joshua M. Stuart, Rosalyn B. Irby & Norman H. Lee. (2010) Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NFκB and microRNA network. Molecular Cancer 9:1.
Crossref
Crossref
T Shrestha-Bhattarai & V M Rangnekar. (2010) Cancer-selective apoptotic effects of extracellular and intracellular Par-4. Oncogene 29:27, pages 3873-3880.
Crossref
Crossref
Luis Fernando Méndez-López, Pablo Zapata-Benavides, Angel Zavala-Pompa, Miguel Elías Aguado-Barrera, Javier Pacheco-Calleros, Cristina Rodríguez-Padilla, Ricardo Martín Cerda-Flores, Elva Irene Cortés-Gutiérrez & Martha Imelda Dávila-Rodríguez. (2010) Immunohistochemical Analysis of Prostate Apoptosis Response-4 (Par-4) in Mexican Women with Breast Cancer: A Preliminary Study. Archives of Medical Research 41:4, pages 261-268.
Crossref
Crossref
Carolina S IlkowSteven D WillowsTom C Hobman. (2010) Rubella virus capsid protein: a small protein with big functions. Future Microbiology 5:4, pages 571-584.
Crossref
Crossref
Susanne VetterkindEunhee Lee, Eric Sundberg, Ransom H. PoythressTerence C. Tao, Ute Preuss & Kathleen G. Morgan. (2010) Par-4: A New Activator of Myosin Phosphatase. Molecular Biology of the Cell 21:7, pages 1214-1224.
Crossref
Crossref
Stefan Grimm & Mathieu Noteborn. (2010) Anticancer genes: inducers of tumour-specific cell death signalling. Trends in Molecular Medicine 16:2, pages 88-96.
Crossref
Crossref
Tae-Jin Lee, Ji-Hoon Jang, Hyo-Jeong Noh, Eun-Jung Park, Kyeong-Sook Choi & Taeg-Kyu Kwon. (2010) Overexpression of Par-4 sensitizes TRAIL-induced apoptosis via inactivation of NF-κB and Akt signaling pathways in renal cancer cells. Journal of Cellular Biochemistry, pages n/a-n/a.
Crossref
Crossref
Meike BoosenSusanne VetterkindJan Kubicek, Karl-Heinz ScheidtmannSusanne Illenberger & Ute Preuss. (2009) Par-4 Is an Essential Downstream Target of DAP-like Kinase (Dlk) in Dlk/Par-4–mediated Apoptosis. Molecular Biology of the Cell 20:18, pages 4010-4020.
Crossref
Crossref
Su-Hyeon Kim, Su-Hyeong Kim, Yong-Beom Kim, Yong-Tark Jeon, Sang-Chul Lee & Yong-Sang Song. (2009) Genistein Inhibits Cell Growth by Modulating Various Mitogen-Activated Protein Kinases and AKT in Cervical Cancer Cells. Annals of the New York Academy of Sciences 1171:1, pages 495-500.
Crossref
Crossref
Su-Hyeon Kim, Yoo-Cheol Song, Su-Hyeong Kim, Hoenil Jo & Yong-Sang Song. (2009) Effect of Epidermal Growth Factor Receptor Inhibitor Alone and in Combination with Cisplatin on Growth of Vulvar Cancer Cells. Annals of the New York Academy of Sciences 1171:1, pages 642-648.
Crossref
Crossref
David S. Libich, Martin Schwalbe, Sachin Kate, Hariprasad Venugopal, Jolyon K. Claridge, Patrick J. B. Edwards, Kaushik Dutta & Steven M. Pascal. (2009) Intrinsic disorder and coiled-coil formation in prostate apoptosis response factor 4. FEBS Journal 276:14, pages 3710-3728.
Crossref
Crossref
Ravshan Burikhanov, Yanming Zhao, Anindya Goswami, Shirley Qiu, Steven R. Schwarze & Vivek M. Rangnekar. (2009) The Tumor Suppressor Par-4 Activates an Extrinsic Pathway for Apoptosis. Cell 138:2, pages 377-388.
Crossref
Crossref
Jeng-Woei Lee, Po-Fan Liu, Lee-Ping Hsu, Peir-Rong Chen, Chung-Hsing Chang & Wen-Ling Shih. (2009) EBV LMP-1 negatively regulates expression and pro-apoptotic activity of Par-4 in nasopharyngeal carcinoma cells. Cancer Letters 279:2, pages 193-201.
Crossref
Crossref
Jeng-Woei Lee, Wei-Ting Hsiao, Kuei-Fang Lee, Lai-Fa Sheu, Hsue-Yin Hsu, Lee-Ping Hsu, Borcherng Su, Moon-Sing Lee, Yih-Chih Hsu & Chung-Hsing Chang. (2009) Widespread expression of prostate apoptosis response-4 in nasopharyngeal carcinoma. Head & Neck, pages NA-NA.
Crossref
Crossref
Lin Ye, Howard Kynaston & Wen G. Jiang. (2008) Bone Morphogenetic Protein-9 Induces Apoptosis in Prostate Cancer Cells, the Role of Prostate Apoptosis Response-4. Molecular Cancer Research 6:10, pages 1594-1606.
Crossref
Crossref
Asfar Sohail Azmi, Zhiwei Wang, Ravshan Burikhanov, Vivek M. Rangnekar, Guoping Wang, Jianyong Chen, Shaomeng Wang, Fazlul H. Sarkar & Ramzi M. Mohammad. (2008) Critical role of prostate apoptosis response-4 in determining the sensitivity of pancreatic cancer cells to small-molecule inhibitor-induced apoptosis. Molecular Cancer Therapeutics 7:9, pages 2884-2893.
Crossref
Crossref
Anindya Goswami, Shirley Qiu, Thomas S. Dexheimer, Padhma Ranganathan, Ravshan Burikhanov, Yves Pommier & Vivek M. Rangnekar. (2008) Par-4 Binds to Topoisomerase 1 and Attenuates Its DNA Relaxation Activity. Cancer Research 68:15, pages 6190-6198.
Crossref
Crossref
Jeng-Woei Lee, Kuei-Fang Lee, Hsue-Yin Hsu, Lee-Ping Hsu, Wen-Ling Shih, Yi-Chih Chu, Wei-Ting Hsiao & Po-Fan Liu. (2007) Protein expression and intracellular localization of prostate apoptosis response-4 (Par-4) are associated with apoptosis induction in nasopharyngeal carcinoma cell lines. Cancer Letters 257:2, pages 252-262.
Crossref
Crossref
Yanming Zhao, Ravshan Burikhanov, Shirley Qiu, Subodh M. Lele, C. Darrell Jennings, Subbarao Bondada, Brett Spear & Vivek M. Rangnekar. (2007) Cancer Resistance in Transgenic Mice Expressing the SAC Module of Par-4. Cancer Research 67:19, pages 9276-9285.
Crossref
Crossref
Takehiko Dohi, Fang Xia & Dario C. Altieri. (2007) Compartmentalized Phosphorylation of IAP by Protein Kinase A Regulates Cytoprotection. Molecular Cell 27:1, pages 17-28.
Crossref
Crossref
Karl Heinz Scheidtmann. (2007) Dlk/ZIP kinase, a novel Ser/Thr-specific protein kinase with multiple functions. Signal Transduction 7:3, pages 248-259.
Crossref
Crossref
Inmaculada Hernandez Gonzalez, Pino Santana, Ignacio Gonzalez-Robayna, Milagros Ferrer, Victoria Morales, Felix Lopez Blanco & Luisa F. Fanjul. (2007) Regulation of the expression of prostate apoptosis response protein 4 (Par-4) in rat granulosa cells. Apoptosis 12:4, pages 769-779.
Crossref
Crossref
Akiko Uchida, Seiki Hirano, Hiroyuki Kitao, Atsuko Ogino, Kanmei Rai, Shinichi Toyooka, Nagio Takigawa, Masahiro Tabata, Minoru Takata, Katsuyuki Kiura & Mitsune Tanimoto. (2007) Activation of downstream epidermal growth factor receptor (EGFR) signaling provides gefitinib-resistance in cells carrying EGFR mutation. Cancer Science 98:3, pages 357-363.
Crossref
Crossref
Sowmyalakshmi Srinivasan, Rama S. Ranga, Ravshan Burikhanov, Seong-Su Han & Damodaran Chendil. (2007) Par-4-Dependent Apoptosis by the Dietary Compound Withaferin A in Prostate Cancer Cells. Cancer Research 67:1, pages 246-253.
Crossref
Crossref
Mary E. Reyland. 2007. Apoptosis, Cell Signaling, and Human Diseases. Apoptosis, Cell Signaling, and Human Diseases
31
55
.
El Bachir Affar, Margaret Po-shan Luke, Frédérique Gay, Dominica Calvo, Guangchao Sui, Robert S. Weiss, En Li & Yang Shi. (2006) Targeted Ablation of Par-4 Reveals a Cell Type–Specific Susceptibility to Apoptosis-Inducing Agents. Cancer Research 66:7, pages 3456-3462.
Crossref
Crossref
Anindya Goswami, Padhma Ranganathan & Vivek M. Rangnekar. (2006) The Phosphoinositide 3-Kinase/Akt1/Par-4 Axis: A Cancer-Selective Therapeutic Target. Cancer Research 66:6, pages 2889-2892.
Crossref
Crossref
Sean M. O'Donnell, Geoffrey H. Holm, Janene M. Pierce, Bing Tian, Melissa J. Watson, Ravi S. Chari, Dean W. Ballard, Allan R. Brasier & Terence S. Dermody. (2006) Identification of an NF-κB-Dependent Gene Network in Cells Infected by Mammalian Reovirus. Journal of Virology 80:3, pages 1077-1086.
Crossref
Crossref
Krishna Murthi Vasudevan, Padhma Ranganathan & Vivek M. Rangnekar. 2006. Regulators and Effectors of Small GTPases: Ras Family. Regulators and Effectors of Small GTPases: Ras Family
422
442
.
PADHMA RANGANATHAN & VIVEK M. RANGNEKAR. (2005) Regulation of Cancer Cell Survival by Par-4. Annals of the New York Academy of Sciences 1059:1, pages 76-85.
Crossref
Crossref
Anindya Goswami, Ravshan Burikhanov, Aurelie de Thonel, Naoya Fujita, Mamta Goswami, Yanming Zhao, John E. Eriksson, Takashi Tsuruo & Vivek M. Rangnekar. (2005) Binding and Phosphorylation of Par-4 by Akt Is Essential for Cancer Cell Survival. Molecular Cell 20:1, pages 33-44.
Crossref
Crossref
Wafik S. El-Deiry. (2005) Meeting Report: The International Conference on Tumor Progression and Therapeutic Resistance. Cancer Research 65:11, pages 4475-4484.
Crossref
Crossref